Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Giorgi G et al. | 2017 | - | magnetic field, 50/60 Hz, signals/pulses, co-exposure | - |
Goodman R et al. | 1992 | isolated organ, salivary glands of <i>Drosophila melanogaster</i> | magnetic field, 50/60 Hz, therapeutic/medical device | 0.38–3.5 mT |
Goodman R et al. | 1992 | isolated organ, salivary glands of <i>Drosophila melanogaster</i> | magnetic field, 50/60 Hz, therapeutic/medical device | 0.38–3.5 mT |
Harada S et al. | 2001 | DNA/RNA, HeLa (DNA mismatch repair-proficient cell extract) | magnetic field, 50/60 Hz | 0.25–1 T |
Heredia-Rojas JA et al. | 2001 | blood samples | magnetic field, 50/60 Hz, co-exposure | 1–2 mT |
Heredia-Rojas JA et al. | 2004 | animal, mouse/CD1 (BALB/c x DBA/2), whole body | magnetic field, 50/60 Hz, co-exposure | 2 mT |
Heredia-Rojas JA et al. | 2017 | mouse/BALB/c | magnetic field, low frequency, 50/60 Hz, co-exposure, also other exposures without EMF | - |
Heredia-Rojas JA et al. | 2018 | animal, mouse/BALB/c | magnetic field, low frequency, 50/60 Hz, electrical substation | - |
Hintenlang DE | 1993 | intact cell/cell culture, human peripheral blood lymphocytes | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 0.6–1.4 mT |
Hisamitsu T et al. | 1997 | intact cell/cell culture, HL-60 and ML-1 cells (human acute myeloid leukaemia cell lines) and human peripheral blood lymphocytes and human peripheral blood polymorphonuclear cells | magnetic field, 50/60 Hz | 45 mT |
Hone P et al. | 2003 | blood sample | magnetic field, 50/60 Hz, co-exposure | 0.23–0.7 mT |
Hone P et al. | 2006 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure | 0.23–0.7 mT |
Hosseinabadi MB et al. | 2019 | human | magnetic field, low frequency, 50/60 Hz, occupational | 11.3–18.9 µT |
Höytö A et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure | - |
Ignataviciene I et al. | 2024 | plant, <i>Lemna minor</i> L. (duckweed) | 50/60 Hz, magnetic field | - |
Ivancsits S et al. | 2002 | intact cell/cell culture, human fibroblasts | magnetic field, 50/60 Hz | 20–2,000 µT |
Ivancsits S et al. | 2003 | intact cell/cell culture, human fibroblasts | magnetic field, low frequency, 50/60 Hz | 20 µT–1 mT |
Ivancsits S et al. | 2003 | intact cell/cell culture, human fibroblasts | magnetic field, 50/60 Hz | 1 mT |
Ivancsits S et al. | 2005 | intact cell/cell culture, human diploid fibroblast cells; SV40-transformed GFSH-R17 rat granulosa cells; human melanocytes; skeletal muscle cells; human monocytes; human lymphocytes | magnetic field, low frequency, 50/60 Hz | 1 mT |
Jajte J et al. | 2001 | intact cell/cell culture, rat lymphocytes | magnetic field, 50/60 Hz | 7 mT |
Jin H et al. | 2015 | intact cell/cell culture, L123 cells (human lung epithelial cells) | magnetic field, 50/60 Hz, co-exposure | 1–2 mT |
Jin YB et al. | 2012 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts) and WI38 cells (human lung fibroblasts), normal and transfected with a c-Myc-containing vector or with an empty vetor | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
Jin YB et al. | 2014 | intact cell/cell culture, NIH3T3 cells (mouse fibroblast cell line), WI-38 cells (human lung fibroblast cells), L-132 (human embryonic lung tissue), MCF10A cells (human breast epithelial cells); partially transfected with a c-Myc or empty vector | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Kesari KK et al. | 2015 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Kesari KK et al. | 2016 | intact cell/cell culture, SH-SY5Y cells (human neuroblastoma cell line) and C6 (rat glioma cell line) | magnetic field, 50/60 Hz | 10–30 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.